These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 18457524

  • 1. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E.
    Expert Rev Neurother; 2008 May; 8(5):687-9. PubMed ID: 18457524
    [No Abstract] [Full Text] [Related]

  • 2. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E.
    Bioessays; 2009 Jun; 31(6):597-9. PubMed ID: 19382231
    [Abstract] [Full Text] [Related]

  • 3. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W, Pawlik M, Sastre M, Jung SS, Radvinsky DS, Klein AM, Sommer J, Schmidt SD, Nixon RA, Mathews PM, Levy E.
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
    Carro E, Torres-Aleman I.
    Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
    [Abstract] [Full Text] [Related]

  • 5. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica ML, Winkler DT, Staufenbiel M, Levy E, Grubb A, Jucker M.
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [Abstract] [Full Text] [Related]

  • 6. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.
    Fisher A.
    Neurodegener Dis; 2008 Dec; 5(3-4):237-40. PubMed ID: 18322400
    [Abstract] [Full Text] [Related]

  • 7. Amyloid imaging in Alzheimer's disease.
    Nordberg A.
    Neuropsychologia; 2008 Dec; 46(6):1636-41. PubMed ID: 18468648
    [Abstract] [Full Text] [Related]

  • 8. Alzheimer's theory makes a splash.
    Schnabel J.
    Nature; 2009 May 21; 459(7245):310. PubMed ID: 19458681
    [No Abstract] [Full Text] [Related]

  • 9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Klunk WE, Mathis CA, Price JC, Lopresti BJ, DeKosky ST.
    Brain; 2006 Nov 21; 129(Pt 11):2805-7. PubMed ID: 17071918
    [No Abstract] [Full Text] [Related]

  • 10. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr 21; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

  • 11. The synaptic Abeta hypothesis of Alzheimer disease.
    Tanzi RE.
    Nat Neurosci; 2005 Aug 21; 8(8):977-9. PubMed ID: 16047022
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE, Kokjohn TA.
    Alzheimers Dement; 2009 Sep 21; 5(5):437-8. PubMed ID: 19751925
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlein R, Bell JM.
    Curr Opin Investig Drugs; 2009 Jul 21; 10(7):672-80. PubMed ID: 19579173
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF, Martone R, Porte A.
    J Med Chem; 2009 Oct 22; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beta amyloid's accomplice? Molecular hit man might help Alzheimer's protein take out brain's white matter.
    Leslie M.
    Sci Aging Knowledge Environ; 2004 Jan 14; 2004(2):nf8. PubMed ID: 14724324
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting the CREB pathway for memory enhancers.
    Tully T, Bourtchouladze R, Scott R, Tallman J.
    Nat Rev Drug Discov; 2003 Apr 14; 2(4):267-77. PubMed ID: 12669026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.